Clinical Trial

ICGA for Vascular Embolism After Hyaluronic Acid Injection

Completed
View on ClinicalTrials.gov →
Summary
Facial vascular embolism following hyaluronic acid injection is a rare but potentially serious complication that may lead to tissue ischemia, necrosis, and scarring. Early assessment of local tissue perfusion is important for evaluating treatment response and predicting clinical outcomes. This retrospective observational study aims to evaluate whether indocyanine green angiography (ICGA) can provide objective, real-time information on tissue perfusion in patients with facial vascular embolism after hyaluronic acid injection. The study will review existing medical records, ICGA imaging data, and follow-up information from patients treated at a single center. The main question is whether ICGA findings before and after initial rescue therapy can help assess early perfusion recovery and identify patients who may require additional intervention or develop persistent tissue damage.
Trial Details
NCT Number NCT07581652
Lead Sponsor Chongli Yu
Collaborators: The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Conditions Embolism Arterial
Enrollment 19 participants
Start Date 2025-07-01
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-12